Tags

Type your tag names separated by a space and hit enter

Long-term survival after stroke: 30 years of follow-up in a cohort, the Copenhagen City Heart Study.
Neuroepidemiology. 2009; 33(3):254-60.N

Abstract

BACKGROUND AND PURPOSE

Only few have studied long-term survival after stroke. Such knowledge is essential for the evaluation of the current and future burden of stroke. The present study presents up to 30 years of follow-up of patients after a first-ever stroke.

METHODS

Participants in the Copenhagen City Heart Study who experienced a first-ever stroke from 1978 to the end of 2001 were followed to the end of 2007. Stroke events were validated using the World Health Organization's definition of stroke. Linkage to the Danish Civil Registration System enabled identification of participants who died before the end of 2007. The National Register of Causes of Death provided cause of death. Survival in stroke patients was compared with survival in participants in the Copenhagen City Heart Study who did not suffer a stroke, and with survival in the general Danish population. Cox regression analyses adjusting for age and gender were used to compare survival in six consecutive 4-year periods starting with 1978-1982.

RESULTS

Of 2,051 patients with first-ever stroke 1,801 died during follow-up. Causes of death were cerebrovascular disease in 37%, other cardiovascular diseases in 28%, cancer in 12%, and other causes in 23%. The most important determinant for long-term survival was age at time of stroke. In the 65- to 72-year age group 11% survived 15 years after stroke. In the age group <65 years 28% survived 15 years. For all age groups survival was poorer in stroke patients than in non-stroke controls. Long-term survival improved steadily over time. Life expectancy after stroke increased up to 4 years from 1978 to the end of 2001, exceeding the increase of life expectancy in the general population. Slightly longer survival was found in women than in men when adjusted for age at stroke onset.

CONCLUSION

In this cohort long-term survival after stroke gradually improved over three decades from 1978. The gain in remaining lifetime after stroke exceeded that of the general population.

Authors+Show Affiliations

Department of Neurology, Bispebjerg Hospital, University of Copenhagen, DK-2400 Copenhagen, Denmark. gb01@bbh.regionh.dkNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

19641331

Citation

Boysen, Gudrun, et al. "Long-term Survival After Stroke: 30 Years of Follow-up in a Cohort, the Copenhagen City Heart Study." Neuroepidemiology, vol. 33, no. 3, 2009, pp. 254-60.
Boysen G, Marott JL, Grønbaek M, et al. Long-term survival after stroke: 30 years of follow-up in a cohort, the Copenhagen City Heart Study. Neuroepidemiology. 2009;33(3):254-60.
Boysen, G., Marott, J. L., Grønbaek, M., Hassanpour, H., & Truelsen, T. (2009). Long-term survival after stroke: 30 years of follow-up in a cohort, the Copenhagen City Heart Study. Neuroepidemiology, 33(3), 254-60. https://doi.org/10.1159/000229780
Boysen G, et al. Long-term Survival After Stroke: 30 Years of Follow-up in a Cohort, the Copenhagen City Heart Study. Neuroepidemiology. 2009;33(3):254-60. PubMed PMID: 19641331.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Long-term survival after stroke: 30 years of follow-up in a cohort, the Copenhagen City Heart Study. AU - Boysen,Gudrun, AU - Marott,Jacob Louis, AU - Grønbaek,Morten, AU - Hassanpour,Houry, AU - Truelsen,Thomas, Y1 - 2009/07/27/ PY - 2009/02/11/received PY - 2009/05/20/accepted PY - 2009/7/31/entrez PY - 2009/7/31/pubmed PY - 2010/5/25/medline SP - 254 EP - 60 JF - Neuroepidemiology JO - Neuroepidemiology VL - 33 IS - 3 N2 - BACKGROUND AND PURPOSE: Only few have studied long-term survival after stroke. Such knowledge is essential for the evaluation of the current and future burden of stroke. The present study presents up to 30 years of follow-up of patients after a first-ever stroke. METHODS: Participants in the Copenhagen City Heart Study who experienced a first-ever stroke from 1978 to the end of 2001 were followed to the end of 2007. Stroke events were validated using the World Health Organization's definition of stroke. Linkage to the Danish Civil Registration System enabled identification of participants who died before the end of 2007. The National Register of Causes of Death provided cause of death. Survival in stroke patients was compared with survival in participants in the Copenhagen City Heart Study who did not suffer a stroke, and with survival in the general Danish population. Cox regression analyses adjusting for age and gender were used to compare survival in six consecutive 4-year periods starting with 1978-1982. RESULTS: Of 2,051 patients with first-ever stroke 1,801 died during follow-up. Causes of death were cerebrovascular disease in 37%, other cardiovascular diseases in 28%, cancer in 12%, and other causes in 23%. The most important determinant for long-term survival was age at time of stroke. In the 65- to 72-year age group 11% survived 15 years after stroke. In the age group <65 years 28% survived 15 years. For all age groups survival was poorer in stroke patients than in non-stroke controls. Long-term survival improved steadily over time. Life expectancy after stroke increased up to 4 years from 1978 to the end of 2001, exceeding the increase of life expectancy in the general population. Slightly longer survival was found in women than in men when adjusted for age at stroke onset. CONCLUSION: In this cohort long-term survival after stroke gradually improved over three decades from 1978. The gain in remaining lifetime after stroke exceeded that of the general population. SN - 1423-0208 UR - https://www.unboundmedicine.com/medline/citation/19641331/Long_term_survival_after_stroke:_30_years_of_follow_up_in_a_cohort_the_Copenhagen_City_Heart_Study_ L2 - https://www.karger.com?DOI=10.1159/000229780 DB - PRIME DP - Unbound Medicine ER -